This study investigates pancreatic cancer in individuals diagnosed with type 2 diabetes within the last 6 months. The purpose of this study is to evaluate if an investigational blood test can detect pancreatic cancer early in these patients.
The study evaluates the effectiveness of the blood test in identifying pancreatic cancer markers. It focuses on whether the test can find signs of cancer at an early stage when treatment may be more effective.
- Who can participate: Adults aged 50 to 84 years who were diagnosed with type 2 diabetes in the last 6 months may be eligible. Participants must be willing to provide blood samples and undergo imaging scans if necessary.
- Study details: Participants will provide blood samples and complete questionnaires during study visits.
- Study timelines and visits: The study will last 12 months. The study requires 3 visits.
How understandable was the trial content above?
Hard to understand
Easy to understand